A Pilot Phase IV, Multicenter, Randomized, Double Blind, Placebo-controlled, Parallel Study To Investigate The Correlation Between Ph Control And Heartburn Symptoms After 14 Days Of Proton Pump Inhibitor Treatment In Subjects With Frequent Heartburn
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Esomeprazole (Primary)
- Indications Heartburn
- Focus Therapeutic Use
- Sponsors Pfizer
- 25 Sep 2018 Primary endpoint (Number of Participants With Relief of 24 Hour Heartburn and Without Relief of 24 Hour Heartburn) has been met, according to results published in the Advances in Therapy.
- 25 Sep 2018 Primary endpoint (Change From Baseline at Day 14 in Percentage of Time Over 24--Hour Period With Intra Gastric pH Greater Than ) has been met, according to results published in the Advances in Therapy.
- 25 Sep 2018 Results published in the Advances in Therapy